share_log
Reuters ·  Mar 31 11:02
Gyre Therapeutics Announces Nmpa Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 2073

Recommended

Write a comment